📣 VC round data is live. Check it out!

Salus Valuation Multiples

Discover revenue and EBITDA valuation multiples for Salus and similar public comparables like Cerus, Arjo, Menicon, Paul Hartmann and more.

Salus Overview

About Salus

Salus is a Slovenia-based company engaged in the wholesale and distribution of medical products. It offers medicines, medical devices, medical supplies, dietary supplements, cosmetics to hospitals, pharmacies, and other customers.


Founded

1969

HQ

Slovenia

Employees

413

Website

salus.si

Financials (FY)

Revenue: $811M
EBITDA: $35M

EV

$612M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Salus Financials

Salus reported last fiscal year revenue of $811M and EBITDA of $35M.

In the same fiscal year, Salus generated $97M in gross profit, $35M in EBITDA, and $19M in net income.


Salus P&L

In the most recent fiscal year, Salus reported revenue of $811M and EBITDA of $35M.

Salus is profitable as of last fiscal year, with gross margin of 12%, EBITDA margin of 4%, and net margin of 2%.

See analyst estimates for Salus
Last FY202320242025202620272028
Revenue$811M$698M$755M$811M
Gross Profit$97M$70M$86M$97M
Gross Margin12%10%11%12%
EBITDA$35M$23M$30M$35M
EBITDA Margin4%3%4%4%
EBIT Margin3%2%3%3%
Net Profit$19M$12M$15M$19M
Net Margin2%2%2%2%
Net Debt$1M---

Financial data powered by Morningstar, Inc.

Salus Stock Performance

Salus has current market cap of $598M, and enterprise value of $612M.

Market Cap Evolution


Salus' stock price is $72.76.

Salus share price decreased by 0.4% in the last 30 days, and increased by 104.9% in the last year.

Salus has an EPS (earnings per share) of $2.36.

See more trading valuation data for Salus
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$612M$598M1.1%-0.4%-7.3%104.9%$2.36

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Salus Valuation Multiples

Salus trades at 0.8x EV/Revenue multiple, and 17.3x EV/EBITDA.

See NTM and 2027E valuation multiples for Salus

Salus Financial Valuation Multiples

As of May 27, 2026, Salus has market cap of $598M and EV of $612M.

Salus has a P/E ratio of 30.8x.

Last FY202320242025202620272028
EV/Revenue0.8x0.9x0.8x0.8x
EV/EBITDA17.3x26.9x20.5x17.3x
EV/EBIT26.7x39.6x31.4x26.7x
EV/Gross Profit6.3x8.7x7.1x6.3x
P/E30.8x50.0x40.0x30.8x
EV/FCF41.7x33.9x65.9x41.7x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Salus Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Salus Margins & Growth Rates

In the most recent fiscal year, Salus reported gross margin of 12%, EBITDA margin of 4%, and net margin of 2%.

See estimated margins and future growth rates for Salus

Salus Margins

Last FY20242025202720282029
Gross Margin12%11%12%
EBITDA Margin4%4%4%
EBIT Margin3%3%3%
Net Margin2%2%2%
FCF Margin2%1%2%

Salus Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth8%7%
Gross Profit Growth22%13%
EBITDA Growth31%19%
EBIT Growth26%17%
Net Profit Growth25%30%
FCF Growth(49%)58%

Data powered by FactSet, Inc. and Morningstar, Inc.

Salus Operational KPIs

Salus' revenue per employee in the last FY averaged $2.0M, while opex per employee averaged $0.2M for the same period.

Access forward-looking KPIs for Salus
Last FY202320242025202620272028
Revenue per Employee$2.0M---
Opex per Employee$0.2M---
S&M Expenses to Revenue6%6%6%6%
G&A Expenses to Revenue3%2%2%3%
Opex to Revenue9%8%9%9%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Salus Competitors

Salus competitors include Cerus, Arjo, Menicon, Paul Hartmann, Universal Vision, Prim, Standard Glass Lining, Tristel, Stille and Bastide Le Confort Médical.

Most Salus public comparables operate across Medical Supplies.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Cerus2.4x2.3x58.8x41.3x
Arjo0.6x0.6x3.7x3.7x
Menicon1.4x1.3x8.9x7.7x
Paul Hartmann0.4x-3.9x-
Universal Vision2.4x2.3x5.2x5.3x
Prim0.9x-6.3x-
Standard Glass Lining----
Tristel3.8x3.5x13.9x12.7x

This data is available for Pro users. Sign up to see all Salus competitors and their valuation data.

Start Free Trial

Salus M&A Activity

Salus has acquired 1 company to date.

Last acquisition by Salus was on August 1st 2025. Salus acquired Farmadent for $9M (EV/Revenue multiple of ).

See M&A valuation multiples

Latest Acquisitions by Salus

Farmadent
Description
Farmadent is a Slovenia-headquartered wholesaler distributing medicines, medical devices, and consumer health products to pharmacies across the Balkans. Based in Ljubljana, it supplies antibiotics, analgesics, and diagnostics from Merck and Roche, maintaining a 20,000-square-meter warehouse. Farmadent holds GDP certification and delivers to 2,000 outlets in Slovenia, Croatia, and Serbia.
HQ CountrySlovenia
HQ City
Maribor
Deal Date1 Aug 2025
Valuation$9M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Salus acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Salus

When was Salus founded?Salus was founded in 1969.
Where is Salus headquartered?Salus is headquartered in Slovenia.
How many employees does Salus have?As of today, Salus has over 413 employees.
Is Salus publicly listed?Yes, Salus is a public company listed on Ljubljana Stock Exchange.
What is the stock symbol of Salus?Salus trades under SALR ticker.
When did Salus go public?Salus went public in 1999.
Who are competitors of Salus?Salus main competitors include Cerus, Arjo, Menicon, Paul Hartmann, Universal Vision, Prim, Standard Glass Lining, Tristel, Stille, Bastide Le Confort Médical.
What is the current market cap of Salus?Salus' current market cap is $598M.
What is the current revenue of Salus?Salus' last fiscal year revenue is $811M.
What is the current EV/Revenue multiple of Salus?Current revenue multiple of Salus is 0.8x.
Is Salus profitable?No, Salus is not profitable.
How many companies Salus has acquired to date?As of May 2026, Salus has acquired 1 company.
What was the largest acquisition by Salus?$9M acquisition of Farmadent on 1st August 2025 was the largest M&A Salus has done to date.
What companies Salus acquired?Salus acquired Farmadent.
In how many companies Salus has invested to date?Salus hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Salus

Lists including Salus

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial